International
The Morning Science

What science found today

‹
 

Policy

FDA Wants Liquid Statin Off Shelves

MedPage Today ·

FDA Wants Liquid Statin Off Shelves

The Brief

  • The FDA wants the liquid simvastatin formulation FloLipid withdrawn from the market.
  • The agency is giving the drugmaker an opportunity for a hearing before any final decision.
  • Approval of the simvastatin oral suspension is at risk, according to MedPage Today's report.

Why it matters

If withdrawal goes ahead, patients and clinicians who rely on the liquid simvastatin form would need an alternative statin formulation.

Who’s affected

  • patients who take liquid simvastatin
  • physicians and pharmacists who prescribe or dispense simvastatin oral suspension

(MedPage Today) -- The FDA wants a liquid formulation of simvastatin (FloLipid) withdrawn from the market, though the agency is giving the drugmaker an opportunity for a hearing. Approval of simvastatin oral suspension is at risk because Salerno...

How do you feel about this?

0 Comments

    FDA Wants Liquid Statin Off Shelves – The Morning Science